283 related articles for article (PubMed ID: 22711662)
1. Promotion of liver regeneration/repair by farnesoid X receptor in both liver and intestine in mice.
Zhang L; Wang YD; Chen WD; Wang X; Lou G; Liu N; Lin M; Forman BM; Huang W
Hepatology; 2012 Dec; 56(6):2336-43. PubMed ID: 22711662
[TBL] [Abstract][Full Text] [Related]
2. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine.
Kim I; Ahn SH; Inagaki T; Choi M; Ito S; Guo GL; Kliewer SA; Gonzalez FJ
J Lipid Res; 2007 Dec; 48(12):2664-72. PubMed ID: 17720959
[TBL] [Abstract][Full Text] [Related]
3. Intestinal FXR-mediated FGF15 production contributes to diurnal control of hepatic bile acid synthesis in mice.
Stroeve JH; Brufau G; Stellaard F; Gonzalez FJ; Staels B; Kuipers F
Lab Invest; 2010 Oct; 90(10):1457-67. PubMed ID: 20531290
[TBL] [Abstract][Full Text] [Related]
4. Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis.
Modica S; Petruzzelli M; Bellafante E; Murzilli S; Salvatore L; Celli N; Di Tullio G; Palasciano G; Moustafa T; Halilbasic E; Trauner M; Moschetta A
Gastroenterology; 2012 Feb; 142(2):355-65.e1-4. PubMed ID: 22057115
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.
Schmitt J; Kong B; Stieger B; Tschopp O; Schultze SM; Rau M; Weber A; Müllhaupt B; Guo GL; Geier A
Liver Int; 2015 Apr; 35(4):1133-1144. PubMed ID: 25156247
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast Growth Factor 21 Response in a Preclinical Alcohol Model of Acute-on-Chronic Liver Injury.
Christidis G; Karatayli E; Hall RA; Weber SN; Reichert MC; Hohl M; Qiao S; Boehm U; Lütjohann D; Lammert F; Karatayli SC
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360670
[TBL] [Abstract][Full Text] [Related]
7. Hepatocyte-specific deletion of farnesoid X receptor delays but does not inhibit liver regeneration after partial hepatectomy in mice.
Borude P; Edwards G; Walesky C; Li F; Ma X; Kong B; Guo GL; Apte U
Hepatology; 2012 Dec; 56(6):2344-52. PubMed ID: 22730081
[TBL] [Abstract][Full Text] [Related]
8. PPARα-UGT axis activation represses intestinal FXR-FGF15 feedback signalling and exacerbates experimental colitis.
Zhou X; Cao L; Jiang C; Xie Y; Cheng X; Krausz KW; Qi Y; Sun L; Shah YM; Gonzalez FJ; Wang G; Hao H
Nat Commun; 2014 Sep; 5():4573. PubMed ID: 25183423
[TBL] [Abstract][Full Text] [Related]
9. Bile acid signaling and liver regeneration.
Fan M; Wang X; Xu G; Yan Q; Huang W
Biochim Biophys Acta; 2015 Feb; 1849(2):196-200. PubMed ID: 24878541
[TBL] [Abstract][Full Text] [Related]
10. The cholesterol-raising factor from coffee beans, cafestol, as an agonist ligand for the farnesoid and pregnane X receptors.
Ricketts ML; Boekschoten MV; Kreeft AJ; Hooiveld GJ; Moen CJ; Müller M; Frants RR; Kasanmoentalib S; Post SM; Princen HM; Porter JG; Katan MB; Hofker MH; Moore DD
Mol Endocrinol; 2007 Jul; 21(7):1603-16. PubMed ID: 17456796
[TBL] [Abstract][Full Text] [Related]
11. Nuclear bile acid receptor FXR in the hepatic regeneration.
Chen WD; Wang YD; Meng Z; Zhang L; Huang W
Biochim Biophys Acta; 2011 Aug; 1812(8):888-92. PubMed ID: 21167938
[TBL] [Abstract][Full Text] [Related]
12. Insufficient bile acid signaling impairs liver repair in CYP27(-/-) mice.
Meng Z; Liu N; Fu X; Wang X; Wang YD; Chen WD; Zhang L; Forman BM; Huang W
J Hepatol; 2011 Oct; 55(4):885-95. PubMed ID: 21334403
[TBL] [Abstract][Full Text] [Related]
13. Bile Acids as Hormones: The FXR-FGF15/19 Pathway.
Kliewer SA; Mangelsdorf DJ
Dig Dis; 2015; 33(3):327-31. PubMed ID: 26045265
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis.
Byun S; Jung H; Chen J; Kim YC; Kim DH; Kong B; Guo G; Kemper B; Kemper JK
J Biol Chem; 2019 May; 294(22):8732-8744. PubMed ID: 30996006
[TBL] [Abstract][Full Text] [Related]
15. Cholesterol-lowering effects of taurine through the reduction of ileal FXR signaling due to the alteration of ileal bile acid composition.
Miyata M; Tanaka T; Takahashi K; Funaki A; Sugiura Y
Amino Acids; 2021 Oct; 53(10):1523-1532. PubMed ID: 34596761
[TBL] [Abstract][Full Text] [Related]
16. Impaired Intestinal Farnesoid X Receptor Signaling in Cystic Fibrosis Mice.
Ikpa PT; Doktorova M; Meijsen KF; Nieuwenhuijze NDA; Verkade HJ; Jonker JW; de Jonge HR; Bijvelds MJC
Cell Mol Gastroenterol Hepatol; 2020; 9(1):47-60. PubMed ID: 31470114
[TBL] [Abstract][Full Text] [Related]
17. Hepatic cholesterol accumulation ascribed to the activation of ileum Fxr-Fgf15 pathway inhibiting hepatic Cyp7a1 in high-fat diet-induced obesity rats.
Duan Y; Zhang F; Yuan W; Wei Y; Wei M; Zhou Y; Yang Y; Chang Y; Wu X
Life Sci; 2019 Sep; 232():116638. PubMed ID: 31288013
[TBL] [Abstract][Full Text] [Related]
18. Effects of essential fatty acid deficiency on enterohepatic circulation of bile salts in mice.
Lukovac S; Los EL; Stellaard F; Rings EH; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2009 Sep; 297(3):G520-31. PubMed ID: 19608735
[TBL] [Abstract][Full Text] [Related]
19. Bile acid promotes liver regeneration via farnesoid X receptor signaling pathways in rats.
Ding L; Yang Y; Qu Y; Yang T; Wang K; Liu W; Xia W
Mol Med Rep; 2015 Jun; 11(6):4431-7. PubMed ID: 25634785
[TBL] [Abstract][Full Text] [Related]
20. Intestinal Farnesoid X Receptor Controls Transintestinal Cholesterol Excretion in Mice.
de Boer JF; Schonewille M; Boesjes M; Wolters H; Bloks VW; Bos T; van Dijk TH; Jurdzinski A; Boverhof R; Wolters JC; Kuivenhoven JA; van Deursen JM; Oude Elferink RPJ; Moschetta A; Kremoser C; Verkade HJ; Kuipers F; Groen AK
Gastroenterology; 2017 Apr; 152(5):1126-1138.e6. PubMed ID: 28065787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
